Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hycult Biotech
Uden, North Brabant, Netherlands
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Hycult Biotech is a leading manufacturer of research reagents (antibodies, proteins, assays) for innate immunity, with a particular focus on the complement system; their products are widely used in research but not in clinical development or for therapeutics[1][2][4][5][9].
- Therapeutic areas
- ImmunologyInfectious DiseasesNeurology
- Modalities
- Monoclonal antibodyPolyclonal antibodyProteinPeptidesAssayRecombinant protein
- Industry
- Non-Drug Biotech
02
Partnerships
SciFiMed consortium (European multi-disciplinary research project with Sanquin for complement biology assay development)Numerous academic and biotechnology collaborators and over 65 distributors worldwide
Beyond the preview
Go deeper on Hycult Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hycult Biotech.